1. Home
  2. CTOS vs EVO Comparison

CTOS vs EVO Comparison

Compare CTOS & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Custom Truck One Source Inc.

CTOS

Custom Truck One Source Inc.

HOLD

Current Price

$6.05

Market Cap

1.4B

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.01

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTOS
EVO
Founded
1988
1993
Country
United States
Germany
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.1B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
CTOS
EVO
Price
$6.05
$3.01
Analyst Decision
Buy
Strong Buy
Analyst Count
3
1
Target Price
$7.33
$7.00
AVG Volume (30 Days)
808.1K
238.0K
Earning Date
10-27-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,936,513,000.00
$887,396,457.00
Revenue This Year
$13.19
N/A
Revenue Next Year
$4.90
$8.80
P/E Ratio
N/A
N/A
Revenue Growth
7.39
N/A
52 Week Low
$3.18
$2.84
52 Week High
$6.78
$5.10

Technical Indicators

Market Signals
Indicator
CTOS
EVO
Relative Strength Index (RSI) 49.15 43.52
Support Level $5.91 $2.87
Resistance Level $6.35 $3.05
Average True Range (ATR) 0.26 0.10
MACD -0.02 0.01
Stochastic Oscillator 56.30 39.19

Price Performance

Historical Comparison
CTOS
EVO

About CTOS Custom Truck One Source Inc.

Custom Truck One Source Inc is a one-stop-shop provider of specialty equipment in the electric utility transmission and distribution, forestry, telecom, waste management, rail, and infrastructure end-markets in North America. The company's segment includes Equipment Rental Solutions (ERS), Truck and Equipment Sales (TES), and Aftermarket Parts and Services (APS). It generates maximum revenue from the TES segment. Geographically, it derives a majority revenue from the United States.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: